StocksMedium•17 November 2026•
1 min read
Intel Shares Fall as Nvidia Cuts Stake; SELLAS Life Sciences Surges on Trial Results
Key Facts
1A regulatory filing revealed that Nvidia reduced its stake in Intel by 25% during the third quarter.
2SELLAS Life Sciences shares surged over 220% following positive late-stage trial results for its cancer vaccine.
3Intel faces a shareholder lawsuit alleging the company concealed the impact of a slowdown in personal computer sales.
Nvidia reduced its stake in Intel by 25% during the third quarter, according to a regulatory filing. Intel is also facing a shareholder lawsuit alleging the company concealed the impact of slowing personal computer sales on its business. Meanwhile, SELLAS Life Sciences shares surged more than 220% following positive late-stage trial results for its experimental cancer vaccine.
Intel closed at $55.47 on November 16, 2026, while Nvidia closed at $156.14 on the same date. SELLAS Life Sciences closed at $7.47 on November 16, 2026, after reaching an intra-day high of $8.39. Among industry peers, AMD closed at $504.28 and TSM closed at $373.45 on November 16, 2026.